BioSpace News Archive

Stiff person syndrome spectrum disorders are rare autoimmune and neurological disorders that most often cause muscle stiffness and spasms in the torso and limbs. According to a small, preliminary study released today, a blood treatment called plasmapheresis, also known as therapeutic plasma exchange, may be a safe way to treat stiff person syndrome spectrum disorders.

The global Pharmaceutical Intermediates market size is estimated to be worth US$ 182100 million in 2021 and is forecast to a readjusted size of US$ 280690 million by 2030 with a CAGR of 6.3% during the forecast period 2022-2030.

A recent report provides crucial insights along with application based and forecast information in the Global Ribostamycin Sulfate Salt Market.

The need to diversify and strengthen the U.S. infant formula supply is more important than ever.

Data Bridge Market Research Published Latest Global Dermatology Diagnostic Devices Market Study by in-depth analysis about current scenario, the Market size, demand, growth pattern, trends, and forecast.

While producing Liposuction Devices market report, combination of best industry insight, practical solutions, talent solutions and latest technology have been utilized.

Data Bridge Market Research Published Latest Global Sperm Penetration Assay Market Study by in-depth analysis about current scenario, the Market size, demand, growth pattern, trends, and forecast.

Product Design and Development Services Market report aids businesses in gaining knowledge about what is already there in the market, what market looks forward to, the competitive background and steps to be followed for outdoing the rivals.

Data Bridge Market Research Published Latest Global Pediatric Neurology Devices Market Study by in-depth analysis about current scenario, the Market size, demand, growth pattern, trends, and forecast.

Portage Biotech Inc., a clinical-stage immuno-oncology company developing therapies to improve patient lives and increase survival by avoiding and overcoming cancer treatment resistance, announced that it has signed an agreement to acquire Tarus Therapeutics, a private company developing adenosine receptor antagonists.